HCA Healthcare (HCA), ADMA Biologics (ADMA) and Exelixis (EXEL) are three medical stocks that you can look into as the sector continues to sustain its end-of-the-year momentum.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The U.S. economy added 353,000 for the month, much better than the Dow Jones estimate for 185,000 (as quoted on CNBC).
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

4 Top Stocks to Buy for Attractive Earnings Growth

08:26am, Wednesday, 07'th Feb 2024
Invest in stocks such as HCA Healthcare (HCA), Powell Industries (POWL), Axos Financial (AX), and Eagle Materials (EXP) for solid earnings growth.
Does HCA Healthcare (HCA) have what it takes to be a top stock pick for momentum investors? Let's find out.

Is Humana's pain HCA Healthcare's gain?

07:46am, Tuesday, 06'th Feb 2024
HCA Healthcare Inc. NYSE: HCA is the largest for-profit hospital company in the United States. The company owns and operates 186 hospitals and nearly 2,400 ambulatory sites, including freestanding eme
A common way that companies amplify shareholder value is through implementing share buybacks. And recently, these three companies have authorized precisely that.

Best Momentum Stocks to Buy for February 2nd

11:01am, Friday, 02'nd Feb 2024
BK, HCA and HOOK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 2, 2023.

New Strong Buy Stocks for February 2nd

07:21am, Friday, 02'nd Feb 2024
USM, BK, KOF, HCA and AX have been added to the Zacks Rank #1 (Strong Buy) List on February 2, 2023.
Stronger-than-expected Q4 earnings on Tuesday helped rectify the notion that these stocks are undervalued making now an ideal time to buy.
Here is how HCA Healthcare (HCA) and HealthEquity (HQY) have performed compared to their sector so far this year.
HCA Healthcare (HCA) expects EPS in the range of $19.70-$21.20 for 2024, the midpoint being 7.6% higher than the 2023 figure.
Although the revenue and EPS for HCA (HCA) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street es
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE